Rozlytrek Pellet
Product Images NDC 50242-623

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rozlytrek (NDC 50242-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rozlytrek 01)

Chemical structure of entrectinib, the active ingredient in Rozlytrek. The diagram shows the molecular arrangement including fluorophenyl groups, piperidine, and piperazine rings characteristic of the compound.*

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Carton)

Label for Rozlytrek (entrectinib) 100 mg oral capsules, supplied in a package of 30 capsules. The label shows the NDC number 50242-091-30 and identifies Genentech, Inc. as the labeler.*

FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Carton)

Rozlytrek (entrectinib) 200 mg capsules label showing a package of 90 capsules. This oral prescription drug is labeled by Genentech, Inc., prominently featuring the drug name, strength, dosage form, and the NDC 50242-094-90.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.